University of Georgia
Microbial glycobiology lab characterizing bacterial glycoconjugate pathways, bacteriophage interactions with their hosts, and benefits of human milk oligosaccharides to develop novel vaccines and therapeutics for the prevention of diarrheal diseases and post-infectious neuropathies such as Guillain-Barré Syndrome.
Disease intervention strategies for important human pathogens and emerging infectious diseases of zoonotic origin; mechanisms of immunity; virus-host interface.
Characterizing the assembly of bacterial surface structures, development of vaccines for viral and bacterial pathogens, systems approaches to understanding microbial diseases
Arenavirus glycoprotein structure and function; virus entry and membrane fusion; emerging virus-host interactions. Functional characterization of viral glycoproteins and host interactions.
Environmental Genomics; Crocodilians; Reptilian Genomics; Molecular Ecology.
We investigate the development and spread of antimicrobial resistant Salmonella, which is the most prevalent foodborne bacterial illness in the U.S.
Veterinary diagnostics; emerging clinical problems; antibiotic resistance;
epidemiology of diseases with special emphasis in zoonoses.
Molecular and cellular biology of the human malaria parasite, Plasmodium falciparum.
Role of reactive oxygen species in host-microbe interactions of the respiratory mucosa, neutrophil biology, pathomechanism of Pseudomonas infection in cystic fibrosis.
Characterization of adhesion proteins which mediate host-parasite interactions in Plasmodium falciparum.
